Clinical Study of Micronized Zmniotic Membrane Transplantation in the Treatment of Chronic and Refractory wounds

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12001889

Enrollment

Unknown

Registered

2012-01-12

Start date

2012-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic and Refractory Wounds

Interventions

Live micronized amniotic membrane group:Live micronized amniotic membrane transplantation

Acellular micronized amniotic membrane group:Acellular micronized amniotic membrane transplanta

Control group:Routine treatment

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 50 years old; 2. Chronic and refractory wounds, including diabetic foot and chronic ulcers; 3. Able and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe and life-threatening illness; 2. Patients with severe Liver failure or heart,kidney,respiratory insufficiency; 3. Serious mental illness; 4. Pregnancy and breast-feeding women, or women with the intention to pregnancy; 5. Patients with malignant cancer; 6. Patients with Stroke or limbs autonomic dysfunction; 7. Participated in other clinical trials last 3 months.

Design outcomes

Primary

Measure	Time frame
Wound healing rate;Scar formation;	—

Countries

China

Contacts

Public ContactZhaofan Xia

xiazhaofan@hotmail.com+86 21 81873471

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026